Navigation Links
VetStem Biopharma CEO, Dr. Robert Harman, will Present Data on Stem Cells for Kidney Disease in Poster Session at Feline Veterinary Conference
Date:9/12/2018

Leading regenerative veterinary medicine company, VetStem Biopharma, will be exhibiting at the American Association of Feline Practitioners Conference (AAFP) later this month. The company’s CEO and founder, Dr. Robert Harman, will be presenting data on adipose-derived stem cell therapy for the treatment of chronic kidney disease in felines at a poster session on Saturday, September 29th. The conference is being held in Charlotte, North Carolina September 27-30, 2018.

At the poster session, Dr. Harman will be presenting and answering questions regarding outcome data collected on 40 clinical cases of chronic kidney disease (CKD) in cats that were treated with adipose-derived stem cell therapy. The authors hypothesized that stem cell therapy could improve the clinical course of CKD. Though informal and unblinded, the study concluded that stem cell therapy may provide clinical benefit and be a low-risk treatment option for cats with chronic CKD.

Additional controlled studies are necessary to further evaluate the benefit of adipose-derived stem cell therapy in CKD however these initial results are promising as recent reviews suggest that CKD may be the number one cause of mortality in older felines. While VetStem’s autologous (patient-derived) stem cell service is available to veterinarians in the United States and Canada, the company has plans to work with the FDA to develop an off-the-shelf donor-derived stem cell product for use in feline disease therapy. Currently, the company has three Investigational New Animal Drug applications filed with the FDA.

As the first company to provide adipose-derived stem cell services to veterinarians across the United States and Canada, VetStem Biopharma is considered a leader in the industry of regenerative veterinary medicine. Over 14,000 animals have been treated utilizing the company’s autologous stem cell service. Dr. Harman has been a trailblazer in the field of regenerative medicine for over a decade and presents at both human and animal medical conferences around the world. He most recently spoke in Sacramento at the 2018 North American Veterinary Regenerative Medicine Association Conference. He applies his biotechnology and veterinary experience in the clinical application of stem cell therapy for various types of injuries, illnesses, and other healing-promoting applications. Dr. Harman has also authored 14 peer-reviewed articles and book chapters.

About VetStem Biopharma, Inc.
VetStem Biopharma is a veterinarian-lead Company that was formed in 2002 to bring regenerative medicine to the profession. This privately held biopharmaceutical enterprise, based near San Diego, California, currently offers veterinarians an autologous stem cell processing service (from patients’ own fat tissue) among other regenerative modalities. With a unique expertise acquired over the past 16 years and 14,000 patients treated by veterinarians for joint, tendon or ligament issues, VetStem has made regenerative medicine applications a therapeutic reality. The VetStem team is focused on developing new clinically practical and affordable veterinary solutions that leverage the natural restorative abilities present in all living creatures. In addition to its own portfolio of patents, VetStem holds exclusive global veterinary licenses to a portfolio of over 70 issued patents in the field of regenerative medicine.

Read the full story at https://www.prweb.com/releases/vetstem_biopharma_ceo_dr_robert_harman_will_present_data_on_stem_cells_for_kidney_disease_in_poster_session_at_feline_veterinary_conference/prweb15749512.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology technology :

1. CEO of VetStem Biopharma, Dr. Robert Harman, to Present Results of Safety Study for Allogeneic Stem Cell Product at Regenerative Medicine Conference
2. New Patent for Adipose Stem Cells Issued to VetStem Biopharma
3. Dr. Bob Harman, CEO of VetStem Biopharma, Speaks on Stem Cells at Local Rotary Club
4. Dr. Bob Harman of VetStem Biopharma to Speak on the Business of Stem Cells at the Wild West Veterinary Conference
5. VetStem Biopharma CEO and Founder, Dr. Bob Harman, Interviewed in New Book "Stem Cell Therapy: A Rising Tide"
6. New Patent for Adipose Stem Cells Issued to VetStem
7. VetStem Biopharma Regenerative Cell Therapy has been Used on over 13,000 Animals
8. VetStem Biopharma, Inc. Founder and CEO, Dr. Robert Harman, will present a clinical abstract on Allogeneic Adipose Stem Cell Bio-Distribution at the Veterinary Orthopedic
9. VetStem Biopharma, Inc., Announces the Opening of its GMP Cell Therapy Manufacturing Facility
10. VetStem Biopharma, Inc. Will Present Data on Two Clinical Conditions and an Industry Overview at the North American Veterinary Regenerative Medicine Association Conference
11. VetStem Biopharma Acquires 24 New Adipose Stem Cell Patents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/13/2018)... ... ... Asymmetrex’s director, James L. Sherley, M.D., Ph.D., asks audiences questions like, ... have the means to measure the number of drug molecules in drug development research ... what’s holding up progress in stem cell medicine.” , “Can you imagine taking an ...
(Date:9/12/2018)... ... September 11, 2018 , ... ... add flat sheet Forward Osmosis (FO) membranes from Fluid Technology Solutions (FTS H2O) ... by FTS H2O are constructed from cellulose triacetate (CTA) material. The highly hydrophilic ...
(Date:9/7/2018)... (PRWEB) , ... September 06, 2018 , ... ... runs from September 25th-28th is a meeting of “The industry’s preeminent event on ... provide drug discovery scientists powerful tools to study these emerging targets in a ...
(Date:9/7/2018)... ... 06, 2018 , ... Akadeum Life Sciences today announced it has appointed George ... and leader of numerous biotech companies. , He most recently served as president ... Thompson Street Capital in St. Louis, MO. Prior to ISTO, he was a ...
Breaking Biology Technology:
(Date:8/31/2018)... Mass. (PRWEB) , ... August 30, 2018 , ... ... Customer Success. Jason has more than 20-years of telecommunications experience and over ten years ... Appia Communications, which was acquired by CallTower in early 2018. , In this ...
(Date:8/29/2018)... ... August 28, 2018 , ... Johanna Dwyer, founder and Chief ... of excellence in the field of intellectual property, and named Daniela Sanchez as ... IP Award aims to encourage and support women in their pursuit of careers ...
(Date:8/26/2018)... ... , ... Maire Mayne, an evidence-based energy healer, today announces ... inflammation and autoimmune disorders and improve overall immune response. , The preclinical research ... data was reported:,     Over 180% increase in overall immunity ...
Breaking Biology News(10 mins):